Brief: Processa Pharmaceuticals Receives Notice Of Delisting From Nasdaq

Processa Pharmaceuticals

22/03/2023 21:51

March 22 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS INC - ON MARCH 22, CO RECEIVED
NOTICE
OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Source: (https://bit.ly/3nbPQ3B)
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))